TMCO6 activators engage in diverse biochemical mechanisms to enhance its functional activity. Compounds that elevate intracellular levels of cAMP facilitate the activation of signaling pathways that TMCO6 is directly involved in. One such activator initiates this process by directly stimulating adenylyl cyclase, resulting in increased cAMP production. Another activator, operating through beta-adrenergic receptor stimulation, leads to a similar rise in cAMP, implicating TMCO6 in the cascade. Additionally, the employment of cAMP analogs serves to bypass upstream elements and directly engage cAMP-dependent pathways, ensuring the activation of TMCO6. Phosphodiesterase inhibitors also elevate cAMP by preventing its breakdown, reinforcing the activation of TMCO6 through these signaling routes.
Similarly, TMCO6 activation is modulated by alterations in intracellular calcium levels. Certain activators function by facilitating the influx of calcium into the cell, either directly as ionophores or indirectly by agonizing calcium channels, thereby initiating calcium-dependent signaling processes that TMCO6 integrates with. Conversely, one compound blocks L-type calcium channels, resulting in an indirect activation of TMCO6 via a compensatory increase in intracellular calcium signaling. Another activator affects intracellular ion balances by inhibiting the Na+/K+-ATPase, leading to sodium and calcium accumulation which then triggers the activation of TMCO6 through calcium-mediated pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which then phosphorylates proteins within signaling cascades that TMCO6 is a part of, leading to its activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
As an agonist of beta-adrenergic receptors, Isoproterenol stimulates pathways that result in the production of cAMP, thereby activating TMCO6 as it participates in cAMP-mediated signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
By increasing intracellular calcium levels, Ionomycin activates calcium-dependent signaling pathways that are essential for the activation of TMCO6. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Directly activates cAMP-dependent pathways, leading to the activation of TMCO6, which is modulated by these pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, facilitating the influx of calcium and activating calcium-dependent pathways that engage TMCO6 activation. | ||||||
Nitrendipine | 39562-70-4 | sc-201466 sc-201466A sc-201466B | 50 mg 100 mg 500 mg | $109.00 $160.00 $458.00 | 6 | |
By blocking L-type calcium channels, Nitrendipine alters calcium signaling, thereby indirectly activating TMCO6 through its involvement in calcium-dependent processes. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX increases intracellular cAMP by inhibiting phosphodiesterases, which in turn activates TMCO6 through cAMP-dependent pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
As a selective inhibitor of phosphodiesterase 4, Rolipram increases levels of cAMP, thereby activating TMCO6 via cAMP-dependent signaling mechanisms. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Acts as an L-type calcium channel agonist, enhancing calcium influx and activating TMCO6 through calcium-dependent signaling pathways. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain inhibits Na+/K+-ATPase, leading to intracellular sodium and calcium accumulation, which activates calcium-dependent pathways that TMCO6 is part of. | ||||||